Yayın:
High Absolute Coronary Disease Risk among Turks: Involvement of Risk Factors Additional to Conventional Ones

dc.contributor.authorOnat, Altan
dc.contributor.authorCan, Guenay
dc.contributor.authorHergenc, Guelay
dc.contributor.authorKucukdurmaz, Zekeriya
dc.contributor.authorUgur, Murat
dc.contributor.authorYuksel, Husniye
dc.date.accessioned2026-06-27T12:52:52Z
dc.date.issued2010
dc.description.abstractObjectives: To confirm previous findings on excess absolute coronary heart disease (CHD) risk among Turks. Methods: The observed incident CHD risk of a representative population sample was compared with that anticipated by Framingham risk scores (FRS). At 7.4 years of follow-up of 3,027 participants free of CHD at baseline, risk estimation was contrasted in the 398 cases of newly developed fatal and nonfatal CHD. Results: CHD developed at a rate 2.2 times higher than the anticipated risk. In sex-specific quintiles of FRS, the 10-year incidence of CHD events in males in the 2 highest quintiles was 2 times the anticipated levels. In women, the 3 highest quintiles displayed an incidence 2.7 times the anticipated risk. Such individuals typically had abdominal obesity and evidence of dysfunctional apolipoprotein (apo) A-I. Men had high levels of non-high-density lipoprotein (HDL) cholesterol, total apoC-III, apoB and triglycerides. In Cox proportional hazard regression analyses, the 10-year probability of remaining free of CHD was low (81.1% in men, 84.2% in women). Women exhibited C-reactive protein as an independent predictor of CHD, lack of protection by HDL cholesterol and no conferred risk from current smoking. The observed excess CHD risk was primarily attributed to central obesity and related dysfunction of HDL, apoC-III and apoA-I. Conclusion: Dysfunction of protective serum proteins associated with metabolic syndrome impacts on CHD events, in addition to conventional risk factors. Copyright (C) 2010 S. Karger AG, Baselen
dc.description.sponsorshipTurkish Society of Cardiology
dc.description.sponsorshipAstraZeneca
dc.description.sponsorshipNovartis
dc.description.sponsorshipPfizer
dc.description.sponsorshipSanofi-Aventis, Istanbul, Turkey
dc.description.urihttps://doi.org/10.1159/000312009
dc.identifier.doi10.1159/000312009
dc.identifier.endpage306
dc.identifier.issn0008-6312
dc.identifier.issue4
dc.identifier.pubmed20395681
dc.identifier.startpage297
dc.identifier.urihttps://hdl.handle.net/20.500.14981/47804
dc.identifier.volume115
dc.identifier.wos000276774900106
dc.language.isoeng
dc.publisherKARGER
dc.relation.ispartofCARDIOLOGY
dc.subjectCoronary disease risk prediction
dc.subjectFramingham risk score
dc.subjectLow-grade inflammation
dc.subjectObesity
dc.subjectRisk factors
dc.subjectTurkish population
dc.subjectHIGH-DENSITY-LIPOPROTEIN
dc.subjectAPOLIPOPROTEIN-A-I
dc.subjectMETABOLIC SYNDROME
dc.subjectCARDIOVASCULAR RISK
dc.subjectHEART-DISEASE
dc.subjectCHOLESTEROL LEVELS
dc.subjectARTERY-DISEASE
dc.subjectFRAMINGHAM
dc.subjectPREDICTION
dc.subjectPOPULATION
dc.subjectCardiovascular System & Cardiology
dc.titleHigh Absolute Coronary Disease Risk among Turks: Involvement of Risk Factors Additional to Conventional Ones
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar